INDSWIFT LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of INDSWIFT LABORATORIES have increased by 6.10% YoY .
The Earnings Per Share (EPS) of INDSWIFT LABORATORIES has increased by 783.87 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
INDSWIFT LABORATORIES Last 5 Annual Financial Results
[BOM: 532305|NSE : INDSWFTLAB]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹1,281 Cr | ₹1,207 Cr | ₹1,039 Cr | ₹891 Cr | ₹780 Cr |
| Expenses | ₹1,027 Cr | ₹978 Cr | ₹843 Cr | ₹709 Cr | ₹636 Cr |
| Operating Profit (Excl OI) | ₹254 Cr | ₹229 Cr | ₹196 Cr | ₹183 Cr | ₹143 Cr |
| Other Income | ₹45 Cr | ₹34 Cr | ₹43 Cr | ₹23 Cr | ₹33 Cr |
| Interest | ₹51 Cr | ₹92 Cr | ₹96 Cr | ₹100 Cr | ₹107 Cr |
| Depreciation | ₹53 Cr | ₹57 Cr | ₹131 Cr | ₹87 Cr | ₹90 Cr |
| Profit Before Tax | ₹582 Cr | ₹87 Cr | ₹13 Cr | ₹18 Cr | ₹-20 Cr |
| Profit After Tax | ₹421 Cr | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr |
| Consolidated Net Profit | ₹421 Cr | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr |
| Earnings Per Share (Rs) | ₹71.24 | ₹8.06 | ₹-0.36 | ₹-0.53 | ₹-3.59 |
| PAT Margin (%) | 32.68 | 3.94 | -0.21 | -0.35 | -2.71 |
| ROE(%) | 58.97 | 10.61 | -0.54 | -0.78 | -5.56 |
| ROCE(%) | 55.13 | 13.25 | 7.88 | 8.31 | 5.97 |
| Total Debt/Equity(x) | 0.01 | 1.71 | 2.33 | 2.56 | 2.48 |
Key Financials |
||
| Market Cap | : | ₹ 631.1 Cr |
| Revenue (TTM) | : | ₹ 726.0 Cr |
| Net Profit(TTM) | : | ₹ 259.8 Cr |
| EPS (TTM) | : | ₹ 44.0 |
| P/E (TTM) | : | 2.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDSWIFT LABORATORIES | 0.7% | 9.1% | 19.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 1% | 4.6% | 47.5% |
| CIPLA | -1.1% | -0.3% | 20.7% |
| DR REDDYS LABORATORIES | 2.2% | 12.1% | 21.6% |
| ZYDUS LIFESCIENCES | -2.7% | 0.8% | 43.8% |
| DIVIS LABORATORIES | 1% | -3.2% | 59.3% |
| MANKIND PHARMA | 0.8% | 12.8% | 52.4% |
| TORRENT PHARMACEUTICALS | -1.5% | 5.9% | 55% |
| LUPIN | 0.9% | 7.2% | 72.7% |
INDSWIFT LABORATORIES Revenues
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | 6.10 % |
| 5 Yr CAGR | 13.22 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,281 Cr | 6.10 | |
| Mar2023 | ₹1,207 Cr | 16.23 | |
| Mar2022 | ₹1,039 Cr | 16.54 | |
| Mar2021 | ₹891 Cr | 14.33 | |
| Mar2020 | ₹780 Cr | - | |
INDSWIFT LABORATORIES Operating Profit
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | 10.91 % |
| 5 Yr CAGR | 15.37 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹254 Cr | 10.91 | |
| Mar2023 | ₹229 Cr | 17.16 | |
| Mar2022 | ₹196 Cr | 7.01 | |
| Mar2021 | ₹183 Cr | 27.41 | |
| Mar2020 | ₹143 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 4.58 % |
| 5 Yr CAGR | 1.91 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 19.85% | 4.58 | |
| Mar2023 | 18.98% | 0.80 | |
| Mar2022 | 18.83% | -8.19 | |
| Mar2021 | 20.51% | 11.47 | |
| Mar2020 | 18.4% | - | |
INDSWIFT LABORATORIES Profit After Tax
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | 784.43 % |
| 5 Yr CAGR | Positive |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹421 Cr | 784.43 | |
| Mar2023 | ₹48 Cr | Positive | |
| Mar2022 | ₹-2.15 Cr | Negative | |
| Mar2021 | ₹-3.15 Cr | Negative | |
| Mar2020 | ₹-21 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 729.44 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 32.68 % | 729.44 | |
| Mar2023 | 3.94 % | Positive | |
| Mar2022 | -0.21 % | Negative | |
| Mar2021 | -0.35 % | Negative | |
| Mar2020 | -2.71 % | - | |
INDSWIFT LABORATORIES Earnings Per Share (EPS)
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | 783.87 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹71 | 783.87 | |
| Mar2023 | ₹8.06 | Positive | |
| Mar2022 | ₹-0.36 | Negative | |
| Mar2021 | ₹-0.53 | Negative | |
| Mar2020 | ₹-3.59 | - | |
INDSWIFT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | 316.08 % |
| 5 Yr CAGR | 74.32 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 55.13% | 316.08 | |
| Mar2023 | 13.25% | 68.15 | |
| Mar2022 | 7.88% | -5.17 | |
| Mar2021 | 8.31% | 39.20 | |
| Mar2020 | 5.97% | - | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹106.8 |
| Current MarketCap | : | ₹ 631.1 Cr |
| Updated EOD on | : | Dec 26,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 0.7% |
9.1% |
19.9% |
| SENSEX | -2.1% |
-2% |
11.3% |
INDSWIFT LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about INDSWIFT LABORATORIES Financials
How the annual revenues of INDSWIFT LABORATORIES have changed ?
The Revenues of INDSWIFT LABORATORIES have increased by 6.10% YoY .
How the Earnings per Share (EPS) of INDSWIFT LABORATORIES have changed?
The Earnings Per Share (EPS) of INDSWIFT LABORATORIES has increased by 783.87 % YoY .
Check out Intrinsic Value of Peers of INDSWIFT LABORATORIES
Compare Stock Analytics of Peers of INDSWIFT LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
